Hepatitis C virus and alcohol.
This review will focus on the prevalence of hepatitis c virus (HCV) infection in alcoholics with and without liver disease. Evidence will be presented to demonstrate that ethanol and chronic HCV infection synergistically accelerate liver injury. Some of the major postulated mechanisms responsible for disease progression include high rates of apoptosis, lipid peroxidation, and generation of free radicals and reactive oxygen species with reduced antioxidant capacity of the liver. Acquisition and persistence of HCV infection may be due to the adverse effects of ethanol on humoral and cellular immune responses to HCV. Dendritic cells (DC) appear to be one of the major targets for ethanol's action and DC dysfunction impairs the ability of the host to generate viral specific cluster of differentiation 4 (CD4+) and cluster of differentiation 8 (CD8+) immune responses. There is a relationship between increased alcohol intake and decreased response to interferon (IFN) therapy, which may be reversed by abstinence. Clinical studies are needed to optimize treatment responses in alcoholic patients with chronic HCV infection.
Siu
Larry
L
Warren Alpert Medical School of Brown University, Providence, Rhode Island 02903, USA.
Foont
Julie
J
Wands
Jack R
JR
D000428:Alcohol Drinking / Q000009:adverse effects*; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D018450:Disease Progression; D000431:Ethanol / Q000633:toxicity*; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology / Q000473:pathology; D006801:Humans; D008108:Liver Diseases, Alcoholic / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology / Q000473:pathology / Q000628:therapy / Q000821:virology; D012307:Risk Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D000431:Ethanol